JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
DFSD
4501
Dimensional Short-Duration Fixed Income ETF
DFSD
$7.27B
| $939K | ﹤0.01% |
20,039
-4,444
| -18% | -$210K |
2023 Q3
5 quarters
|
|
4502
Philips
PHG
$23.4B
| $939K | ﹤0.01% |
40,090
-225,545
| -85% | -$5.83M |
2013 Q2
46 quarters
|
|
4503
Enanta Pharmaceuticals
ENTA
$377M
| $938K | ﹤0.01% |
163,113
-80,515
| -33% | -$772K |
2016 Q1
35 quarters
|
|
4504
Olema Pharmaceuticals
OLMA
$719M
| $937K | ﹤0.01% |
160,751
-20,281
| -11% | -$203K |
2020 Q4
16 quarters
|
|
|
WBA
4505
PUT
DELISTED
Walgreens Boots Alliance
WBA
| $933K | ﹤0.01% |
100,000
| – | – |
2020 Q3
17 quarters
|
|
|
BSCP
4506
DELISTED
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
| $929K | ﹤0.01% |
44,976
+43,688
| +3,392% | +$902K |
2023 Q4
4 quarters
|
|
4507
Microvision
MVIS
$45.3M
| $928K | ﹤0.01% |
47,235
+41,229
| +686% | +$650K |
2016 Q4
32 quarters
|
|
4508
CALL
T. Rowe Price
TROW
$22.3B
| $927K | ﹤0.01% |
8,200
| – | – |
2023 Q1
7 quarters
|
|
4509
Seanergy Maritime Holdings
SHIP
$386M
| $927K | ﹤0.01% |
133,360
+75,079
| +129% | +$674K |
2023 Q3
5 quarters
|
|
4510
Lifezone Metals
LZM
$346M
| $927K | ﹤0.01% |
133,356
+65,340
| +96% | +$437K |
2023 Q4
4 quarters
|
|
4511
GoPro
GPRO
$279M
| $927K | ﹤0.01% |
850,218
+521,450
| +159% | +$663K |
2014 Q3
41 quarters
|
|
4512
Chemung Financial Corp
CHMG
$395M
| $925K | ﹤0.01% |
18,946
+9,226
| +95% | +$461K |
2022 Q4
8 quarters
|
|
4513
Harbor Ares Systematic High Yield ETF
SIHY
$155M
| $924K | ﹤0.01% |
+20,277
| New | +$935K |
2024 Q4
0 quarters
|
|
|
PBPB
4514
DELISTED
Potbelly
PBPB
| $924K | ﹤0.01% |
98,124
+31,071
| +46% | +$282K |
2017 Q3
29 quarters
|
|
|
BLTE
4515
Belite Bio
BLTE
$6.43B
| $924K | ﹤0.01% |
14,636
+8,280
| +130% | +$546K |
2023 Q4
4 quarters
|
|
4516
eHealth
EHTH
$21.5M
| $917K | ﹤0.01% |
97,601
+93,615
| +2,349% | +$520K |
2016 Q2
34 quarters
|
|
|
GBTG
4517
DELISTED
American Express Global Business Travel
GBTG
| $917K | ﹤0.01% |
98,770
-2,357
| -2% | -$20.1K |
2023 Q2
6 quarters
|
|
4518
Digital Turbine
APPS
$1.35B
| $916K | ﹤0.01% |
541,825
+153,991
| +40% | +$343K |
2018 Q3
25 quarters
|
|
4519
Overlay Shares Hedged Large Cap Equity ETF
OVLH
$108M
| $916K | ﹤0.01% |
26,830
+19,063
| +245% | +$656K |
2023 Q1
7 quarters
|
|
4520
Trevi Therapeutics
TRVI
$1.98B
| $913K | ﹤0.01% |
221,664
+121,147
| +121% | +$388K |
2023 Q2
6 quarters
|
|
4521
J. Jill
JILL
$369M
| $912K | ﹤0.01% |
33,016
-2,227
| -6% | -$57.4K |
2017 Q4
28 quarters
|
|
|
HCVI
4522
DELISTED
Hennessy Capital Investment Corp. VI Class A Common Stock
HCVI
| $910K | ﹤0.01% |
+86,046
| New | +$907K |
2024 Q4
0 quarters
|
|
4523
Tenaris
TS
$28.3B
| $909K | ﹤0.01% |
24,067
-48,063
| -67% | -$1.71M |
2015 Q3
37 quarters
|
|
4524
USCB Financial Holdings
USCB
$417M
| $906K | ﹤0.01% |
51,043
+31,357
| +159% | +$547K |
2021 Q4
12 quarters
|
|
4525
Organogenesis Holdings
ORGO
$171M
| $899K | ﹤0.01% |
280,997
+75,054
| +36% | +$252K |
2019 Q1
23 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.